...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Novartis Phase III study shows Canakinumab reduces MACE events

 Should we rely on something from one of the company's Power Point slides?  I mean....they do have a history of typos :-)

Just to be clear, I am totally being a smart aleck here....although aleck isn't the word I would use under normal circumstances.  Heading out again, this time for a nephew's grade 8 graduation.....hopefully shorts are trying to cover off those 800+ thousand they were short up to June 15th....It'd be nice to get back this evening and check in to find the PPS gained at least a cent or two. 

Share
New Message
Please login to post a reply